Newsletters
The Capitalist Newsletter – December 20, 2016
OVERSTOCK LAUNCHES TØ PLATFORM; BEGINS TRADING SHARES VIA BITCOIN BLOCKCHAIN |
|
Winners & Losers – Loxo Oncology, Inc. (LOXO) Soars UP (25.83%) After Seeing 85% Enrollment of Company’s Goal for Mid Stage Trials and Revealing Four Product Candidates in Company’s Pipeline Aimed at Treating Genetically Defined Cancers – Jakks Pacific, Inc. Tanks DOWN (32.62%) After Drastic Outlook Cut Most Talked About Clovis Oncology, Inc. (CLVS) a Majority Strong Buy After Receiving Early FDA Approval for Advanced Cancer Drug The TIP Sheets – Monday, December 19th – Clovis Oncology, Inc. (CLVS) a Spikes UP (8.82%) After Receiving Early FDA Approval by 3 Months for Advanced Ovarian Cancer Drug. Expect Shares to Continue UP Unusual Volume – Globalstar, Inc. (GSAT) Leaps UP (28.57%) on 38m Shares Traded After FCC is Reportedly Set to Consider New Proposal From Company Following Previous Plan Being Shot Down. Look For Shares to Continue UP |